Download Files:
PD 113413
SKU
HY-113702-Get quote
Category Reference compound
Tags Angiotensin-converting Enzyme (ACE), Cardiovascular Disease, Metabolic Enzyme/Protease
Products Details
Product Description
– PD 113413 is formed by subsequent hydrolysis of the diketopiperazine quinapril analog. PD 113413 is a potent angiotensin-converting enzyme inhibitor. PD 113413 can be used for research of hypertension and congestive heart failure[1].
Web ID
– HY-113702
Shipping
– Room temperature
Molecular Formula
– C23H24N2O4
References
– [1]Kaplan HR, et, al. Quinapril–a preclinical review of the pharmacology, pharmacokinetics, and toxicology. Angiology. 1989 Apr;40(4 Pt 2):335-50.
CAS Number
– 103733-50-2
Molecular Weight
– 392.45
SMILES
– O=C1[C@@]2([H])N(C([C@H](C)N1[C@H](C(O)=O)CCC3=CC=CC=C3)=O)CC4=CC=CC=C4C2
Clinical Information
– No Development Reported
Research Area
– Cardiovascular Disease
Solubility
– 10 mM in DMSO
Target
– Angiotensin-converting Enzyme (ACE)
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.